Low CD86 expression is a predictive biomarker for clinical response to the therapeutic human papillomavirus vaccine IGMKK16E7: results of a post hoc analysis.
Ando H, Katoh Y, Kobayashi O, Ikeda Y, Yahata H, Iwata T, Satoh T, Akiyama A, Maeda D, Hori-Hirose Y, Uemura Y, Nakayama-Hosoya K, Katoh K, Nakajima T, Taguchi A, Komatsu A, Kamata S, Tomita N, Kato K, Aoki D, Igimi S, Kawana-Tachikawa A, Schust DJ, Kawana K.
Ando H, et al. Among authors: tomita n.
JNCI Cancer Spectr. 2024 Nov 1;8(6):pkae091. doi: 10.1093/jncics/pkae091.
JNCI Cancer Spectr. 2024.
PMID: 39302712
Free PMC article.
Clinical Trial.